New Covid pill from Merck

The battle against Covid-19 has been focused on vaccines, but now there is a new development that may be able to help alongside mass vaccinations. We spoke with Doctor Jun Wang from the University of Arizona about a new pill that Merck has created.

To begin the conversation host Ted Simons asked the doctor to simply explain the pill.

Wang responded, “This is an anti-viral drug candidate that has a long history. It was not actually originally developed to target or inhibit the Coronavirus, it was actually originally developed to inhibit or target a few other viruses. Later on, this molecule has also been found to inhibit a number of other viruses; for example, ebola and, most importantly, the flu virus. Actually, right before the Covid-19 pandemic, this molecule was in a clinical trial for influenza variant infection, but with the Covid-19 outbreak the company which originally developed this molecule called the ridgeback, they wanted to see if this molecule works against the Sars-Cov-2 virus or not, which is the virus that caused the Covid-19 pandemic. And the interesting thing is from the experiment and the animal studies using mice, this molecule shows good efficacy in inhibiting Sars-Cov-2.”

Sponsor message:

In this segment:

Dr. Jun Wang, Associate Professor University of Arizona College of Pharmacy

Sponsor message:

Independent Lens: Philly D.A. Part One and Two

Go inside the emotional, high-stakes work that Philadelphia District Attorney Larry Krasner and an ensemble of outsiders from different walks of life as they attempt an overhaul of an entrenched criminal justice system.

Nova 'Picture a Scientist'

Women make up less than a quarter of STEM professionals in the United States, and numbers are even lower for women of color.

Finding Your Roots “The New World”

Henry Louis Gates, Jr. traces the ancestors of actor John Lithgow and journalist Maria Hinojosa who thrived in North America before the birth of the U.S.